Cell Viability Assay Protocols
GUIDELINE
Cell viability is defined as the number of healthy cells in a sample. The measurement of cell viability plays an important role in all forms of cell culture. Sometimes it is the main purpose of the experiment as in toxicity assays, or it can be used to correlate cell behavior to the number of cells. Researchers apply various types of assays to screen the outcome of developing therapeutics that often target cancer cells.
METHODS
MTT assay protocol
- Discard media from cell cultures. For adherent cells, carefully aspirate the media. For suspension cells, spin the 96 well plates at 1000 x g, 4°C for 5 minutes in a microplate-compatible centrifuge and carefully aspirate the media. An alternative method is to add an equal volume of MTT solution to the existing media in the culture. Ensure that the same volume of existing media is present for each sample.
- Add 50 µL of serum-free media and 50 µL of MTT solution into each well.
- Incubate the plate at 37°C for 3 hours.
- After incubation, add 150 µL of MTT solvent into each well.
- Wrap the plate in foil and shake on an orbital shaker for 15 minutes. Occasionally, pipetting of the liquid may be required to fully dissolve the MTT formazan.
- Read absorbance at OD=590 nm. Read the plate within 1 hour.
WST-8 protocol
- Cell suspensions seeded to 96-well plates (100 µl/well) with or without the test compounds are incubated at 37°C in a humidified incubator with 5% CO2 for the required exposure time.
- 10 µL of WST-8 reagent solution is added to each well and the plate is incubated at 37°C for 2 hr. After incubation, the absorbance is measured at 450 nm with a multi-plate reader.
MTS assay protocol
- Prepare cells and test compounds in 96-well plates containing a final volume of 100 µl/well. An optional set of wells can be prepared with medium only for background subtraction.
- Incubate for a desired period of exposure.
- Add 20 µl MTS solution containing PES to each well (the final concentration of MTS will be 0.33 mg/ml).
- Incubate for 1-4 hours at 37°C.
- Record absorbance at 490 nm.
Creative Bioarray Relevant Recommendations
- Creative Bioarray is capable of providing various options for cell viability assays and compound profiling services based on cell viability. We also offer cell viability-related kits such as Calcein AM Cell Viability Assay Kit, Live/Dead Cell Viability Assay Kit, Cell Viability Fluorometric Assay Kit, and others.
NOTES
- Using a tightly controlled and consistent source of cells to set up experiments.
- Performing appropriate characterization of reagent concentration and incubation time for each experimental model system.
RELATED PRODUCTS & SERVICES
For research use only. Not for any other purpose.
Resources
- FAQ
- Posters & Downloads
- Protocol
- Cell Culture Guide
- Technical Bulletins
-
Explore & Learn
-
Cell Biology
- Monocytes vs. Macrophages
- How to Detect and Remove Endotoxins in Biologics?
- Comparison of Different Methods to Measure Cell Viability
- CFU Assay for Hematopoietic Cell
- Techniques for Cell Separation
- Biomarkers and Signaling Pathways in Tumor Stem Cells
- Circulating Tumor Cells as Cancer Biomarkers in the Clinic
- What Are Myeloid Cell Markers?
- How to Start Your Culture: Thawing Frozen Cells
- Comparison of the MSCs from Different Sources
- How to Isolate and Analyze Tumor-Infiltrating Leukocytes?
- Contamination of Cell Cultures & Treatment
- Generation and Applications of Neural Stem Cells
- Stem Cell Markers
- Cell Cryopreservation Techniques and Practices
- Guidelines for Cell Banking to Ensure the Safety of Biologics
- What Is Cell Proliferation and How to Analyze It?
- Direct vs. Indirect Cell-Based ELISA
- Critical Quality Attributes and Assays for Induced Pluripotent Stem Cells
- STR Profiling—The ID Card of Cell Line
- Comparison of Several Techniques for the Detection of Apoptotic Cells
- How to Assess the Migratory and Invasive Capacity of Cells?
- Cryopreservation of Cells Step by Step
- What are PBMCs?
- T Cell Activation and Expansion
- Quantification of Cytokines
- What Cell Lines Are Commonly Used in Biopharmaceutical Production?
- Isolation, Expansion, and Analysis of Natural Killer Cells
- Neural Differentiation from Induced Pluripotent Stem Cells
- IL-12 Family Cytokines and Their Immune Functions
- Tumor Stem Cells: Identification, Isolation and Therapeutic Interventions
- Multi-Differentiation of Peripheral Blood Mononuclear Cells
- How to Scale Up Single-Cell Clones?
- What are Mesothelial Cells?
- Major Problems Caused by the Use of Uncharacterized Cell Lines
- T Cell, NK Cell Differentiation from Induced Pluripotent Stem Cells
- Cell Culture Medium
- Human Primary Cells: Definition, Assay, Applications
- What are the Differences Between M1 and M2 Macrophages?
- Mesenchymal Stem Cells: A Comprehensive Exploration
- Enrichment, Isolation and Characterization of Circulating Tumor Cells (CTCs)
- Tips For Cell Cryopreservation
- How to Decide Between 2D and 3D Cell Cultures?
- Organoid Differentiation from Induced Pluripotent Stem Cells
- Unveiling the Molecular Secrets of Adipogenesis in MSCs
- Troubleshooting Cell Culture Contamination: A Comprehensive Guide
- CHO Cell Line Development
- How to Eliminate Mycoplasma From Cell Cultures?
- Strategies for Enrichment of Circulating Tumor Cells (CTCs)
- How to Isolate PBMCs from Whole Blood?
- How to Handle Mycoplasma in Cell Culture?
- How to Interpret ddPCR Results: Common Pitfalls and Troubleshooting
- ddPCR Assay Design for Gene Rearrangement Detection
- Cell Culture Troubleshooting: Molecular Diagnostics & QC for Preclinical R&D
- Cell Immortalization Step by Step
- Adherent and Suspension Cell Culture
- Optimization Strategies of Cell-Based Assays
- Live Cell Imaging: Unveiling the Dynamic World of Cellular Processes
- Overview of Cell Apoptosis Assays
- Cell-Based High-Throughput Screening Techniques
- From Collection to Cure: How ACT Works in Cancer Immunotherapy
- Role of Cell-Based Assays in Drug Discovery and Development
- What are White Blood Cells?
- Types of Cell Therapy for Cancer
- Immunogenicity Testing: ELISA and MSD Assays
- From Blur to Clarity: Solving Resolution Limits in Live Cell Imaging
- ddPCR vs qPCR vs NGS: Which Platform Fits Your Research?
- Key Techniques in Primary, Immortalized and Stable Cell Line Development
- From Primary to Immortalized: Navigating Key Cell Lines in Biomedical Research
- Cell Viability, Proliferation and Cytotoxicity Assays
- Eosinophils vs. Basophils vs. Neutrophils
- What Are CAR T Cells?
- Cultivated Meat: What to Know?
- What Are the Pros and Cons of Adoptive Cell Therapy?
- 3D-Cell Model in Cell-Based Assay
- How to Maximize Efficiency in Cell-Based High-Throughput Screening?
- Understanding Immunogenicity Assays: A Comprehensive Guide
- Exploring Cell Dynamics: Migration, Invasion, Adhesion, Angiogenesis, and EMT Assays
- A Complete Guide to Immortalized Cancer Cell Lines in Cancer Research
- Mastering Cell Culture and Cryopreservation: Key Strategies for Optimal Cell Viability and Stability
- Spheroid vs. Organoid: Choosing the Right 3D Model for Your Research
-
Histology
- Fluorescent Nuclear Staining Dyes
- Stains Used in Histology
- Troubleshooting in Fluorescent Staining
- Immunohistochemistry Controls
- Overview of the FFPE Cell Pellet Product Lines
- How to Apply NGS Technologies to FFPE Tissues?
- Overview of Common Tracking Labels for MSCs
- Comparison of Membrane Stains vs. Cell Surface Stains
- Microscope Platforms
- Cell Lysates: Composition, Properties, and Preparation
- Multiple Animal Tissue Arrays
- Immunohistochemistry Troubleshooting
- Cell and Tissue Fixation
- Tips for Choosing the Right Protease Inhibitor
- Mitochondrial Staining
- Guides for Live Cell Imaging Dyes
- Instructions for Tumour Tissue Collection, Storage and Dissociation
- Common Immunohistochemistry Stains and Their Role in Cancer Diagnosis
- How Immunohistochemistry Makes the Invisible Brain Visible?
- Histological Staining Techniques: From Traditional Chemical Staining to Immunohistochemistry
- How to Choose the Right Antibody for Immunohistochemistry (IHC)
- What You Must Know About Neuroscience IHC?
- Modern Histological Techniques
- From Specimen to Slide: Core Methods in Histological Practice
- Multiplexing Immunohistochemistry
- Comparing IHC, ICC, and IF: Which One Fits Your Research?
- Serum vs. Plasma
- How to Begin with Multiplex Immunohistochemistry (mIHC)
-
Exosome
- Collection of Exosome Samples and Precautions
- Current Research Status of Milk Exosomes
- How do PELN Deliver Drugs?
- Classification, Isolation Techniques and Characterization of Exosomes
- Emerging Technologies and Methodologies for Exosome Research
- How Important are Lipids in Exosome Composition and Biogenesis?
- Common Techniques for Exosome Nucleic Acid Extraction
- Exosome Size Measurement
- What are the Functions of Exosomal Proteins?
- How to Apply Exosomes in Clinical?
- Exosomes as Emerging Biomarker Tools for Diseases
- How to Perform Targeted Modification of Exosomes?
- Techniques for Exosome Quantification
- Production of Exosomes: Human Cell Lines and Cultivation Modes
- How to characterize exosomes?
- Summary of Approaches for Loading Cargo into Exosomes
- Exosome Transfection for Altering Biomolecular Delivery
- Exosome Antibodies
- Exosome Quality Control: How to Do It?
- Applications of MSC-EVs in Immune Regulation and Regeneration
- The Role of Exosomes in Cancer
- How to Enhancement Exosome Production?
- Unraveling Biogenesis and Composition of Exosomes
- What's the Potential of PELN in Disease Treatment?
- How to Label Exosomes?
- How to Efficiently Utilize MSC Exosomes for Disease Treatment?
-
ISH/FISH
- ISH probe labeling method
- Multiple Approaches to Karyotyping
- In Situ Hybridization Probes
- CARD-FISH: Illuminating Microbial Diversity
- Comprehensive Comparison of IHC, CISH, and FISH Techniques
- RNAscope ISH Technology
- Multiple Options for Proving Monoclonality
- FISH Techniques for Biofilm Detection
- Whole Chromosome Painting Probes for FISH
- Overview of Common FISH Techniques
- Guidelines for the Design of FISH Probes
- Small RNA Detection by ISH Methods
- Differences Between DNA and RNA Probes
- Overview of Oligo-FISH Technology
- FISH Tips and Troubleshooting
- How to Use FISH in Hematologic Neoplasms?
- What are the Differences between FISH, aCGH, and NGS?
- Comparative Genomic Hybridization and Its Applications
- Telomere Length Measurement Methods
- Different Types of FISH Probes for Oncology Research
- What Types of Multicolor FISH Probe Sets Are Available?
- What Is the Use of FISH in Solid Tumors?
- Reagents Used in FISH Experiments
- What are Single, Dual, and Multiplex ISH?
- Mapping of Transgenes by FISH
- ImmunoFISH: Integrates FISH and IL for Dual Detection
- 9 ISH Tips You Can't Ignore
-
Toxicokinetics & Pharmacokinetics
- Organoids in Drug Discovery: Revolutionizing Therapeutic Research
- How to Improve the Pharmacokinetic Properties of Peptides?
- What Are Metabolism-Mediated Drug-Drug Interactions?
- How to Improve Drug Plasma Stability?
- How Is the Cytotoxicity of Drugs Determined?
- Toxicokinetics vs. Pharmacokinetics
- Traditional vs. Novel Drug Delivery Methods
- Key Factors Influencing Brain Distribution of Drugs
- Overview of In Vitro Permeability Assays
- The Rise of In Vitro Testing in Drug Development
- Predictive Modeling of Metabolic Drug Toxicity
- Effects of Cytochrome P450 Metabolism on Drug Interactions
- How to Improve Drug Distribution in the Brain
- Key Considerations in Toxicokinetic
- Organ-on-a-Chip Systems for Drug Screening
- How to Design and Synthesize Antibody Drug Conjugates?
- What factors influence drug distribution?
- Parameters of Pharmacokinetics: Absorption, Distribution, Metabolism, Excretion
- What Is the Role of the Blood-Brain Barrier in Drug Delivery?
- Physical and Chemical Properties of Drugs and Calculations
- Experimental Methods for Identifying Drug-Drug Interactions
- How to Conduct a Bioavailability Assessment?
- What are the Pharmacokinetic Properties of the Antisense Oligonucleotides?
- What Are Compartment Models in Pharmacokinetics?
- Methods of Parallel Artificial Membrane Permeability Assays
- Pharmacokinetics Considerations for Antibody Drug Conjugates
- Comparison of MDCK-MDR1 and Caco-2 Cell-Based Permeability Assays
- Unraveling the Role of hERG Channels in Drug Safety
- Pharmacokinetics of Therapeutic Peptides
- How Genotoxicity Testing Guides Safer Drug Development
- Top 5 Pitfalls in In Vitro ADME Assays and How to Avoid Them
- 2D vs 3D Cell Culture Models: Which Is Best for Drug Toxicity Testing?
- The Bioanalysis Masterclass: Labile Metabolites
- What Are Biomarkers in Drug Discovery?
- What Is Genotoxicity in Pharmacology? Mechanisms and Sources
- Preclinical Workflow for Drug Toxicity Testing
- Bioanalysis Errors: How to Spot and Fix Them Early
- Troubleshooting Common Issues in Drug Toxicity Testing
- A Complete Guide to CYP Reaction Phenotyping in 2026
- In Vitro ADME vs In Vivo ADME
- How to Interpret CYP Phenotyping Data
- Mastering the Noise: A Practical Guide to Minimizing Variability in Preclinical Studies
- Reaction Phenotyping vs. Metabolic Stability
- Comparing Plasma Protein Binding Methods
- The 8 Costliest Mistakes in Preclinical CYP Phenotyping
- The Essentials of Quantitative Bioanalysis
- Why iPSC-derived Cells are Useful in Toxicology?
- How Are Biomarkers Validated in Drug Development?
- When Should You Introduce ADME Tox Testing in Drug Development?
- Biomarkers vs. Functional Assays: Closing the Preclinical Gap
- Why Cardiotoxicity Matters in R&D?
- 6 Easy Steps to Get Your In Vitro ADME Done
- From Cells to Systems: Modern Approaches to Disease Modeling
- How Can You Optimize Drug Toxicity Assessment?
- How to Choose the Right In Vitro ADME Assays for Small-Molecule Drugs
- The 8 Types of Drug Toxicity Every Researcher Must Know
- What Are the Best Methods to Test Cardiotoxicity?
-
Disease Models
- Animal Models of Neurodegenerative Diseases
- Disease Models of Diabetes Mellitus
- Summary of Advantages and Limitations of Different Oncology Animal Models
- What Human Disease Models Are Available for Drug Development?
- Overview of Cardiovascular Disease Models in Drug Discovery
- Why Use PDX Models for Cancer Research?
- Preclinical Models of Acute Liver Failure
- Bridging the Translational Gap: A Systematic Framework for Model Selection
- Advanced Organoid Culture: A Practical Optimization Guide
- Are You Choosing the Right Preclinical Model? 10 Key Questions
- How to Match Models to Drug Modalities: Small Molecules vs. Biologics
- How to Select the Right Preclinical Model for Drug Development
- Organoids vs Organ-on-Chip: Which is More Predictive?
- Humanized Mouse Models: Core Technical Considerations
- Animal Models vs. NAMs: Understanding Modern Preclinical Research
- How to Select the Right Humanized Mouse Model for Immuno-Oncology
- Static vs. Dynamic In Vitro Models
- Implementing NAMs in Drug Development
- Oncology Model Strategy: From Screening to Validation
- Organ-on-a-Chip: Is Your Microfluidic Setup Ready for Preclinical Trials?
- Why Oncology Organoids Fail? How to Build Models That Work
-
Cell Biology
- Life Science Articles
- Download Center
- Trending Newsletter


